I have too many stories to tell. I'm at a large academic center and I see several Anti-NMDAr/autoimmune cases per month. We currently have 3 on our service right now including an anti-LG1. I'm not an expert, but I'm surrounded by a department of them and we have an autoimmune encephalitis clinic here where patients follow longitudinally after treatment. We see quite a few seronegative AIE cases as well and work with our neuroimmunology department and fellows pretty regularly. I'll post some cases later, but some quick thoughts from stuff above.
A few things I'd disagree with:
3. Every patient I have seen with NMDA-R encephalitis has had catatonic features, often overlooked or eclipsed by their other symptoms (e.g. seizures, coma, delirium). If you read cases reported in the literature, there is usually catatonia often undiagnosed. Catatonia, rather than delusions or hallucinations, should be the key feature that would prompt further workup.
While catatonia is very common with AIE (likely somewhere between 50-60% from larger studies) it is not uncommon to see patients with AIE without catatonia. However, I do agree that catatonia without an obvious cause (psychiatric or medical) should raise concerns for possible AIE.
6. Patients can respond very well to psychotropic medications (or ECT) without immunotherapy. This can sometimes lead the diagnosis to be missed until the patient relapses or dramatically deteriorates.
I don't think I've seen any cases of verified AIE where a patient got better without steroids or immunotherapy. I've seen some cases where we did ECT and patients improved enough that certain neurologists here said, "See, it was psych all along!", but Idk that I've seen anyone with verified AIE improve without direct treatment. As you mentioned above, catatonia is very common with AIE and ECT should absolutely be considered, but data as to whether catatonia actually benefits the underlying AIE is still dubious, though imo is worth plenty of further investigation. I've tried to see if there was any possibility of this where I'm at, but our PACU/anesthesia department already limits us severely in terms of how much ECT we're allowed to do, so I've basically been told there's no chance it would happen.
7. Patients often need high doses of psychotropics in addition to immunotherapy. Some people have this fantasy that you just treat the underlying condition and all will be well, but that is not the case. If it were I'd be out of a job.
Yes and no? Ime the psychiatric symptoms are much like treating delirium. Some patients do require significant psychotropics to manage symptoms and treating the underlying issue doesn't magically make them better. However, I'd question what it means when we say they "need" psychotropics other than agitation management.
15. The APE-2 score is really a very useful tool in assessing likelihood a patient has AE.
APE-2 is fine, certainly a decent tool if one isn't using anything, but RITE-2 has much better specificity and is nearly as sensitive.
Things I agree with that I'd emphasize further:
If you think the patient might have an autoimmune or other cause for their symptoms as indicated by their presentation (e.g. subacute course, episodic memory loss, seizures, MRI findings) or risk factors (e.g. prior HSV infection, past COVID, autoimmunity, malignancy) then they need to have a proper workup considering all the potential causes autoimmune or otherwise. I seem to be seeing less of this in recent years at least.
Just ordering an autoimmune panel and shipping it off to Mayo isn't an appropriate work-up. There needs to be a full reversible-cause of encephalopathy work-up which includes EEG monitoring, MRI w/ and w/o contrast, nurtitional panel, and LP at the very least. We let neuro handle this where I'm at, but we follow these patients closely.
2. Something like 5% of patients with schizophrenia have positive antibodies and these are innocent bystanders in the majority of cases. Positive serum labs are not necessary pathogenic, whereas if found in the CSF they are. Fewer than 1% of these patients have positive CSF antibodies.
Serum labs don't matter and are pointless other than confirming you should get an LP. Anyone where we legitimately suspect has AIE gets tapped. Period.
4. It would be very unusual for these patients to have normal cognitive testing. Isolated psychiatric symptoms with normal cognitive testing would be highly unlikely to be an autoimmune etc case. At the minimum ask your patients to draw a clock!
Completely agree but will add a caveat. I've had 2-3 patients who we (psych) was convinced should get a full AIE work-up but neuro pushed back because EEG and MRI were negative and then patient had several hours or a day where they were lucid before becoming encephalopathic again. Neuro was only convinced to tap them after we started steroids and patient improved. Every one of those cases came back seropositive. That said, even those patients were encephalopathic >95% of the time.
8. Be careful with antipsychotics, especially high potency neuroleptics, as these patients are at high risk of NMS
Not only NMS, but may worsen psychotic symptoms as well. Classic AIE patient is tried on 2-3 antipsychotics and just seems to get worse on them (especially those which are highly anti-dopaminergic like risperdal or haldol) paradoxically. Antipsychotics worsening psychosis should be a huge red flag.
13. Bear in mind diagnostic overshadowing too - it is possible for patients to have BOTH a primary psych disorder (e.g. bipolar or schizophrenia) AND develop autoimmune encephalitis. Similarly, it is possible for patients to have functional neurological symptoms in the setting of AE. It can sometimes be hard to tease apart things, and some patients may have a signficant unrelated psych history. Some patients (or more often, family members) may wish to ascribe everything to some antibodies, but the reality is often more complicated.
I've seen this too and it is not only very hard to untangle the co-morbidities, but it's also often very hard to convince neurology that it's not a pure psych problem.
14. Seronegative autoimmune encephalitis is a thing. However if the patient only has psych symptoms with normal or non-specific MRI findings, bland CSF, no seizures, no cognitive symptoms etc then they don't have a compelling profile for seronegative AE. Some people think the dx means that we should just presumptive treat classic psych issues as if they could be seronegative AE which is misguided.
Imo it's probably a much more common thing than we realize. When I first worked with consults in 2019, Mayo's AIE panel only had 6 auto-antibodies on it. Today the panel has around 30 auto-antibodies they test for and they've added 4 more since the last time I met with the Mayo Lab reps last fall. However, per a recent meta-analysis I saw (will try and find it again) 95% of seronegative cases have significant clinical symptoms and other findings (MRI, EEG, etc). If the clinical signs aren't there, pushing for aggressive treatment should be questioned.
16. People often have this idea that patients magically get better with immunotherapy, and the reality is in most cases it is a long recovery, often requiring rehab and risk of relapsing symptoms (unless there is a clear tumor etc that can be resected). Neuropsych symptoms can also persistent even when the disease has been effectively treated with immunotherapies. Just as with viral encephalitis, then can be lasting damage to the brain. That said, it is a much better diagnosis to have in terms of treatability than a lot of the neurodegenerative disorders that can present w/ psychiatric symptoms.
Some patients do make great, full recoveries, but it rarely resolves quickly and often takes months or over a year to fully recover. Also agree that some patients also never fully recover. Plenty of the patients in our f/up clinic still have sequelae 3-4 years after resolution of symptoms (I'm not aware of patients we have who recovered further in the past than that as the clinic here has only been around a few years).